Regeneron Pharmaceuticals (REGN)

Net Change in Cash

-$1.86B

Quarterly · Period ending: · USD

REGN logo

REGN Net Change in Cash

Latest reported-$1.86B
REGN Quarterly Net Change in Cash (-$4.20M → -$1.86B)
High-resolution chart · PNG

REGN net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
-1,863,300,000
-153,100,000
610,600,000
497,500,000
-1,077,400,000
604,000,000
477,200,000
83,600,000
-681,600,000
-128,000,000
577,600,000
210,500,000
-1,979,100,000
809,400,000
-385,400,000
96,200,000
49,400,000
461,100,000
-546,800,000
1,360,200,000
634,300,000
-756,900,000
620,700,000
-418,100,000
-216,000,000
590,400,000
233,000,000
339,300,000
-663,000,000
240,800,000
379,857,000
169,967,000
-101,615,000
206,758,000
20,668,000
47,752,000
-67,460,000
276,570,000
-385,156,000
273,851,000
42,294,000
-204,888,000
154,515,000
264,033,000
-117,353,000
-140,812,000
2,165,000
46,419,000
138,277,000
-73,750,000
272,397,000
-118,464,000
201,313,000
-49,914,000
111,278,000
-52,945,000
-222,642,000
-89,025,000
277,215,000
-47,917,000
118,936,000
22,804,000
-212,714,000
213,286,000
-5,311,000
-89,764,000
-43,246,000
-21,145,000
72,369,000
-48,699,000
-66,888,000
22,555,000
-228,746,000
21,950,000
401,509,000
-12,227,000
-46,841,000
-81,392,000
70,214,000
52,702,000
-67,372,000
-2,176,000
8,415,000
30,892,000
-2,615,000
52,587,000
-3,813,000
-17,786,000
-51,201,000
55,749,000
-180,332,000
168,958,000
-61,927,000
111,509,000
4,503,000
6,200,000
-66,095,000
-111,924,000
147,419,000
-42,981,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.